Anthony L. Boral, Chief Medical Officer at Blueprint Medicines Corp (BPMC), sold 8,900 shares at $69.59 ($624K) on 2017-11-06, disclosed to the SEC on 2017-11-08.
Open-market sale of $624k BPMC by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $69.59 | 2,380 | $166K | 26.5% |
| 2 | $69.59 | 2,380 | $166K | 26.5% |
| 3 | $70.29 | 1,520 | $107K | 17.1% |
| 4 | $70.29 | 1,520 | $107K | 17.1% |
| 5 | $71.69 | 700 | $50K | 8.0% |
| 6 | $72.87 | 200 |
| $15K |
| 2.3% |
| 7 | $74.00 | 200 | $15K | 2.4% |
| Total | $70.17 avg | 8,900 | $624K | 100% |
| Filing → |
| BPMC | SELL | 2020-09-21 | $1.9M | — | Filing → |
| BPMC | SELL | 2020-03-11 | $28K | — | Filing → |
| BPMC | SELL | 2019-12-19 | $1.5M | — | Filing → |